Symposium: Translating the Translational Sciences - Different Understanding, Common Aim 2

Moderator(s)

• 

  Sibylle Neuhoff, PhD (she/her/hers)

  Senior Scientific Advisor & Deputy Head of Translational Sciences (DMPK)
  Certara Predictive Technologies
  Sheffield, England, United Kingdom

Presentations:

• 9:00 AM – 9:30 AM MT

  Clinical Measurement:  Biomarker versus Clinical Outcome Assessment
  

  Speaker: John Wagner, MD, PhD – Koneksa Health
• 9:30 AM – 10:00 AM MT

  Summarizing the Most Promising Biomarkers to Inform on DDI Magnitude
  

  Speaker: Sibylle Neuhoff, PhD (she/her/hers) – Certara Predictive Technologies
• 10:00 AM – 10:30 AM MT

  Reverse Translational Approach to Mitigate Drug-Induced Immunogenicity at Clinical Stages
  

  Speaker: Saleem Shaik – Takeda Pharmaceutical Company Limited
• 10:30 AM – 11:00 AM MT

  Translational, Clinical Pharmacology Considerations and Learnings From Approved AAV Therapies
  

  Speaker: Hardik R. Mody, PhD (he/him/his) – Genentech